Caring Brands, Inc.

We are a wellness consumer products company offering over-the-counter (OTC) and cosmetic consumer products. Our product pipeline includes hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, a jellyfish sting protective suncare line, and women's sexual wellness products. Our operational approach ensures that the mechanism of action for all products is established, efficacy is determined through controlled clinical trials, products are protected by issued and filed patents, and products have acceptable commercial stability. We are authorized to issue a total of 100,000,000 shares of common stock with a par value of $0.001. As of June 30, 2025, we had 13,336,925 shares of common stock outstanding. We reported nominal revenues and a loss of $6,278,191 for the year ended December 31, 2025, and nominal revenues and a net loss of $1,517,431 for the year ended December 31, 2024. Our product, Photocil, was commercially launched in India in Q3 2022 as a treatment for vitiligo and psoriasis. It was also briefly launched in the United States from December 2022 until February 2023 but was removed due to insufficient sales. We are currently preparing for its relaunch in the United States.